Percentage of episodes with an International Normalized Ratio (INR) test performed three to seven days after a newly started interacting anti-infective medication for individuals receiving warfarin
Number of episodes in the denominator with an INR test performed three to seven days after the start date of an anti-infective medication
Denominator
1.15 Denominator
Number of episodes with a newly started interacting anti-infective medication with an overlapping days’ supply of warfarin.
Exclusions
Exclusions
We excluded the following individuals from the denominator: • Individuals with a diagnosis of cancer • Individuals who are monitoring INR at home
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Patient Safety Spring Cycle 2019
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
Centers for Medicare & Medicaid Services
Steward POC email
Helen.Dollar-Maples@cms.hhs.gov
Steward Organization Copyright
Limited proprietary coding is contained in the measure specifications for user convenience. Use of these codes may require permission from the code owner or agreement to a license.
Public Comments